We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

cbdMD Inc (YCBD) USD0.001

Sell:$0.35 Buy:$0.36 Change: $0.0078 (2.28%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$0.35
Buy:$0.36
Change: $0.0078 (2.28%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$0.35
Buy:$0.36
Change: $0.0078 (2.28%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

cbdMD, Inc. produces and distributes cannabidiol (CBD) products. The Company owns and operates CBD brands cbdMD, Paw CBD, and functional mushroom brand ATRx Labs. Its cbdMD brand of products includes a range of every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixes; and sleep, focus and calming aids. Its Paw CBD brand of products includes a line of veterinarian-formulated products, including tinctures, chews, topicals products in varying strengths and formulas. Its ATRx brand was developed using the power of functional mushrooms to provide consumers with a complementary natural ingredient solution for immunity, focus, digestive health, cognitive, and mood benefits. cbdMD, Paw CBD, and ATRx products are distributed through its e-commerce Websites, third party e-commerce sites, select distributors, and marketing partners, as well as a variety of brick-and-mortar retailers.

Contact details

Address:
8845 Red Oak Blvd
CHARLOTTE
28217-5593
United States
Telephone:
+1 (704) 4453060
Website:
https://www.cbdmd.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
YCBD
ISIN:
US12482W3097
Market cap:
$1.94 million
Shares in issue:
5.54 million
Sector:
Pharmaceuticals
Exchange:
-
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • T. Ronan Kennedy
    Chief Executive Officer, Chief Financial Officer, Director
  • Sibyl Swift
    Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
  • Lance Blundell
    General Counsel

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.